z-logo
open-access-imgOpen Access
Bugs as Cancer Drugs: Challenges and Opportunities
Author(s) -
Phillip J. Daschner,
Avraham Rasooly,
Jeffrey D. White
Publication year - 2019
Publication title -
molecular and cellular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.14
H-Index - 327
eISSN - 1067-8824
pISSN - 0270-7306
DOI - 10.1128/mcb.00206-19
Subject(s) - cancer therapy , cancer , radiation therapy , biology , cancer drugs , intensive care medicine , chemotherapy , cancer treatment , solid tumor , cancer chemotherapy , cancer research , medicine , genetics
The first nonsurgical cancer therapy was bacterial therapy introduced in 1891 to treat solid tumors. Because in many cases it was harmful and ineffective, and with the emergence of radiotherapy and chemotherapy, bacterial therapy was discontinued.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom